Diadema Partners »

Aardvark Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $209k 16k 13.13

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option (RNA)
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
BlackRock
Vanguard Group
Adage Capital Partners GP
Millennium Management
Silverarc Capital Management
Geode Capital Management
State Street Corporation
Centiva Capital
Cantor Fitzgerald, L. P.
Northern Trust
Superstring Capital Management
Two Sigma Investments

View all funds holding Aardvark Therapeutics